Georgia Valsami

Cited by

	All	Since 2019
Citations	2692	1432
h-index	29	20
i10-index	68	47

360

180

270

1992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320248 10 15 10 17 8 7 22 9 21 9 15 18 32 52 39 47 56 73 65 70 85 81 68 129 121 137 187 227 249 282 345 136

Public access

View all

2 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Panos MacherasDepartment of Pharmacy, National and Kapodistrian University of AthensVerified email at pharm.uoa.gr
Aris DokoumetzidisNational & Kapodistrian University of AthensVerified email at pharm.uoa.gr
EIRINI CHRISTODOULOUVerified email at pharm.uoa.gr
Nikolaos KadoglouAssistant Professor of Cardiology, University of CyprusVerified email at ucy.ac.cy
Paraskevi PapakyriakopoulouPharmacist, PhD, School of Pharmacy, National and Kapodistrian University of AthensVerified email at pharm.uoa.gr
Andreas TzakosAssociate ProfessorVerified email at cc.uoi.gr
Thomas MavromoustakosNational and Kapodistrian University of Athens, Department of ChemistryVerified email at chem.uoa.gr
Tsaroucha ADemocritus University of ThraceVerified email at med.duth.gr
Maria ChatziathanasiadouResearch AssociateVerified email at imperial.ac.uk
Gaia ColomboUniversità di FerraraVerified email at unife.it
Maria SkouroliakouVerified email at hua.gr
Tahsin F. KelliciAssociate Principal Scientist, Computational Chemist, Merck & Co, USVerified email at merck.com
Ioanna AthanasiadouDopingkontroll-Labor, Chemical Analytics, Seibersdorf Labor GmbHVerified email at chem.uoa.gr
Kostas AnagnostopoulosLaboratory of Biochemistry, Department of Medicine, Democritus University of Thrace, AlexandroupolisVerified email at med.duth.gr
Costas GeorgakopoulosLaboratory of Pharmaceutical Analysis, Faculty of Pharmacy, National and Kapodistrian University ofVerified email at pharm.uoa.gr
Maria VertzoniNational and Kapodistrian University of Athens, Department of Pharmacy, Associate ProfessorVerified email at pharm.uoa.gr
Dimitrios RekkasAssociate Professor, Department of Pharmacy, National and Kapodistrian University of AthensVerified email at pharm.uoa.gr
Clemens GlaubitzProfessor for Biophysical Chemistry, Goethe University FrankfurtVerified email at em.uni-frankfurt.de
Paraskevas DallasAssistant Professor, National and Capodistrian University of AthensVerified email at pharm.uoa.gr
Christos TsalikidisDemocritus University of ThraceVerified email at med.duth.gr

Georgia Valsami

Professor Department of Pharmacy, National & Kapodistrian University of Athens

Verified email at pharm.uoa.gr

biopharmaceutics pharmacokinetic/pharmacodynamics pharmaceutics pharmacy


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio E Rinaki, G Valsami, P Macheras Pharmaceutical research 20, 1917-1925, 2003	254	2003
Saffron: a natural product with potential pharmaceutical applications E Christodoulou, NPE Kadoglou, N Kostomitsopoulos, G Valsami Journal of Pharmacy and Pharmacology 67 (12), 1634-1649, 2015	209	2015
The power law can describe the ‘entire’drug release curve from HPMC-based matrix tablets: a hypothesis E Rinaki, G Valsami, P Macheras International journal of pharmaceutics 255 (1-2), 199-207, 2003	114	2003
Identification of biowaivers among class II drugs: theoretical justification and practical examples E Rinaki, A Dokoumetzidis, G Valsami, P Macheras Pharmaceutical Research 21, 1567-1572, 2004	107	2004
The impact of maternal-and neonatal-associated factors on human milk's macronutrients and energy K Dritsakou, G Liosis, G Valsami, E Polychronopoulos, M Skouroliakou The Journal of Maternal-Fetal & Neonatal Medicine 30 (11), 1302-1308, 2017	101	2017
Investigation of the interactions of silibinin with 2-hydroxypropyl-β-cyclodextrin through biophysical techniques and computational methods TF Kellici, D Ntountaniotis, G Leonis, M Chatziathanasiadou, ... Molecular pharmaceutics 12 (3), 954-965, 2015	69	2015
Development of a reaction-limited model of dissolution: Application to official dissolution tests experiments A Dokoumetzidis, V Papadopoulou, G Valsami, P Macheras International journal of pharmaceutics 355 (1-2), 114-125, 2008	65	2008
Mapping the interactions and bioactivity of quercetin⿿(2-hydroxypropyl)-β-cyclodextrin complex TF Kellici, MV Chatziathanasiadou, D Diamantis, AV Chatzikonstantinou, ... International Journal of Pharmaceutics 511 (1), 303-311, 2016	61	2016
Improved outcomes of feeding low birth weight infants with predominantly raw human milk versus donor banked milk and formula K Dritsakou, G Liosis, G Valsami, E Polychronopoulos, M Skouroliakou The Journal of Maternal-Fetal & Neonatal Medicine 29 (7), 1131-1138, 2016	56	2016
Complexation studies of cyclodextrins with tricyclic antidepressants using ion-selective electrodes GN Valsami, MA Koupparis, PE Macheras Pharmaceutical research 9, 94-100, 1992	56	1992
Solubilization and quantification of lycopene in aqueous media in the form of cyclodextrin binary systems M Vertzoni, T Kartezini, C Reppas, H Archontaki, G Valsami International journal of pharmaceutics 309 (1-2), 115-122, 2006	55	2006
Serum and tissue pharmacokinetics of silibinin after per os and iv administration to mice as a HP-β-CD lyophilized product E Christodoulou, IA Kechagia, S Tzimas, E Balafas, N Kostomitsopoulos, ... International journal of pharmaceutics 493 (1-2), 366-373, 2015	54	2015
Determination of association constants in cyclodextrin/drug complexation using the Scatchard plot: Application to β-cyclodextrin-anilinonaphthalenesulfonates EE Sideris, GN Valsami, MA Koupparis, PE Macheras Pharmaceutical research 9, 1568-1574, 1992	51	1992
Biopharmaceutics classification systems for new molecular entities (BCS-NMEs) and marketed drugs (BCS-MD): theoretical basis and practical examples V Papadopoulou, G Valsami, A Dokoumetzidis, P Macheras International journal of pharmaceutics 361 (1-2), 70-77, 2008	46	2008
Studies on the interaction of diflunisal ion with cyclodextrins using ion-selective electrode potentiometry EE Sideris, GN Valsami, MA Koupparis, PE Macheras European journal of pharmaceutical sciences 7 (4), 271-278, 1999	44	1999
Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems K Manta, P Papakyriakopoulo, M Chountoulesi, DA Diamantis, ... Molecular Pharmaceutics 17 (11), 4241-4255, 2020	43	2020
Crocus sativus L. aqueous extract reduces atherogenesis, increases atherosclerotic plaque stability and improves glucose control in diabetic atherosclerotic animals E Christodoulou, NPE Kadoglou, M Stasinopoulou, OA Konstandi, ... Atherosclerosis 268, 207-214, 2018	42	2018
Construction of a naproxen ion-selective electrode and its application to pharmaceutical analysis GN Valsami, PE Macheras, MA Koupparis Analyst 114 (3), 387-391, 1989	42	1989
Potential pharmaceutical applications of quercetin in cardiovascular diseases P Papakyriakopoulou, N Velidakis, E Khattab, G Valsami, I Korakianitis, ... Pharmaceuticals 15 (8), 1019, 2022	40	2022
Silibinin effect on Fas/FasL, HMGB1, and CD45 expressions in a rat model subjected to liver ischemia-reperfusion injury AK Tsaroucha, G Valsami, N Kostomitsopoulos, M Lambropoulou, ... Journal of Investigative Surgery 31 (6), 491-502, 2018	40	2018

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors